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Introduction {#sec005}
============

Primary percutaneous coronary intervention (PCI) has dramatically reduced the mortality of ST-segment elevation myocardial infarction (STEMI) \[[@pone.0237362.ref001], [@pone.0237362.ref002]\]. Although most of the culprit lesions for STEMI are totally occluded, it is technically easier to achieve successful reperfusion in primary PCI as compared to PCI to chronic total occlusion (CTO), which are also totally occluded \[[@pone.0237362.ref003], [@pone.0237362.ref004]\]. However, it is sometimes difficult to achieve successful reperfusion even in primary PCI \[[@pone.0237362.ref005]\]. Delayed reperfusion, which results in poor clinical outcomes \[[@pone.0237362.ref006], [@pone.0237362.ref007]\], can consequently lead to long fluoroscopy-time in primary PCI. Moreover, long fluoroscopy-time would be associated with increased rates of periprocedural complications including early mortality, emergent CABG, contrast-induced nephropathy \[[@pone.0237362.ref006]\]. Thus, it is important for better patient's outcomes to recognize which types of lesions require long fluoroscopy-time in primary PCI. The purpose of this study was to investigate the association of the long fluoroscopy-time with clinical factors in primary PCI.

Methods {#sec006}
=======

Study lesions {#sec007}
-------------

We identified consecutive 624 patients with STEMI in the Saitama Medical Center, Jichi Medical University from January, 2015 to December, 2018. We excluded cases that did not have PCI to the culprit lesion, because of medical therapy alone or surgical therapy to the culprit lesion. We also excluded non-emergent PCI cases, unsuccessful PCI cases, and cases in which ≥2 vessels were treated simultaneously. We defined the long fluoroscopy-time group as the longest quintile of fluoroscopy time (Q5), and defined the conventional fluoroscopy-time group as the other quintiles of fluoroscopy time (Q1-Q4). This study was approved by the Institutional Review Board of Saitama Medical Center, Jichi Medical University, and written informed consent was waived because of the retrospective study design.

Primary PCI procedures {#sec008}
----------------------

PCI procedures were performed on a biplane fluoroscopy system (Artis zee BC and Artis zee BA, Siemens, Munich, Germany), with three magnetic fields (16 cm, 20 cm, and 25 cm for Artis zee BC; 16 cm, 22 cm, and 32 cm for Artis zee BA) and a standard image acquisition program at 15 frames per second during cine acquisition and 7.5 frames per second during fluoroscopy. Primary PCI was performed using standard techniques via the radial artery, femoral artery, or rarely brachial artery. First, we advanced a conventional guidewire across the lesion, and used a small (2.0-mm diameter) balloon or thrombus aspiration catheter. The choice of devices was at the discretion of the interventional cardiologist. Activated coagulation time was maintained for \>250 seconds during PCI. IVUS was routinely used for almost all lesions.

Definition {#sec009}
----------

Acute myocardial infarction (AMI) was defined based on universal definition of myocardial infarction \[[@pone.0237362.ref007]\]. STEMI was diagnosed in the presence of new ST elevation at the J point in at least 2 contiguous leads ≥2 mm (0.2 mV) \[[@pone.0237362.ref008], [@pone.0237362.ref009]\]. Hypertension was defined as medical treatment for hypertension and/or a history of hypertension before admission \[[@pone.0237362.ref010]\]. Dyslipidemia was defined as a total cholesterol level ≥ 220 mg/dL or low-density lipoprotein cholesterol level ≥ 140 mg/dL or medical treatment for dyslipidemia or a history of dyslipidemia \[[@pone.0237362.ref010]\]. Diabetes mellitus was defined as a hemoglobin A1c level ≥ 6.5% (as NGSP value) or medical treatment for diabetes mellitus or a history of diabetes mellitus \[[@pone.0237362.ref010]\]. We calculated the estimated glomerular filtration rate (eGFR) from the serum creatinine level, age, weight, and gender using the following formula: eGFR = 194 × Cr-1.094 × age-0.287 (male), eGFR = 194 × Cr-1.094 × age-0.287 × 0.739 (female) \[[@pone.0237362.ref011]\].

Angiographical analysis {#sec010}
-----------------------

Quantitative coronary angiography (QCA) parameters were measured using a cardiovascular angiography analysis system (QAngio XA 7.3, MEDIS Imaging Systems, Leiden, Netherlands). The definition of lesion characteristics including lesion length, eccentricity, tortuosity, lesion angle, ostial lesion, bifurcation lesion has been previously described \[[@pone.0237362.ref012]\]. In an original ACC/AHA definition, tortuosity was defined as follows: stenoses distal to two bends were defined as moderately tortuous, and those distal to three or more bends were defined as excessive tortuosity \[[@pone.0237362.ref012]\]. However, since the above definition of tortuosity has poor objectivity, we additionally defined tortuosity as follows: "≤1" moderate to excessive bend (\<120°) was defined as mild tortuosity, "2" moderate to excessive bends (\<120°) was defined as moderate tortuosity, and "≥3" moderate to excessive bends (\<120°) was defined as excessive tortuosity. Calcification was identified as readily apparent radiopacities within the vascular wall at the site of the stenosis, and was classified as none/mild, moderate (radiopacities noted only during the cardiac cycle before contrast injection), and severe (radiopacities noted without cardiac motion before contrast injection generally compromising both sides of the arterial lumen) \[[@pone.0237362.ref013]\].

Statistical analysis {#sec011}
--------------------

Data are shown as the mean ± SD or percentage. Categorical variables are presented as numbers (percentage), and were compared using the Pearson χ2 test. Continuous variables were compared between the groups using the unpaired Student's t test. Univariate and multivariate logistic regression analyses were performed to find the association between clinical variables and the long fluoroscopy-time. In this model, the long fluoroscopy-time, which was defined as ≥33 minute, was used as the dependent variable. In the multivariate stepwise logistic regression model, the selection of independent variables was derived from the results of univariate logistic regression analysis (P \<0.05 in univariate analysis). However, variables with missing values were not included in the model. The multivariate logistic regression analysis with likelihood ratio statistical criteria using backward elimination method was performed. The odds ratio (OR) and the 95% confidence interval (CI) were also calculated. A P value \<0.05 was considered statistically significant. We analyzed all data by SPSS ver. 24 for Windows (SPSS, Inc., Chicago, Illinois).

Results {#sec012}
=======

During the study period, we had 624 STEMI cases in our medical center. We excluded 53 cases that did not have PCI to the culprit lesion, 27 non-emergent PCI cases, 4 cases in which ≥2 vessels were treated simultaneously, and 1 unsuccessful PCI case. Our final study population was 539 patients, and divided into the long fluoroscopy-time group (n = 105) and the conventional fluoroscopy-time group (n = 434). The study flowchart is shown in [Fig 1](#pone.0237362.g001){ref-type="fig"}.

![The study flow chart.\
Abbreviations: CAG = coronary angiography, PCI = percutaneous coronary intervention.](pone.0237362.g001){#pone.0237362.g001}

The comparison of clinical, lesion and procedural characteristics is shown in [Table 1](#pone.0237362.t001){ref-type="table"}. The lesion length was significantly longer in the long fluoroscopy-time group (22.5 ± 13.6 mm) than in the conventional fluoroscopy-time group (15.9 ± 7.2 mm) (P \< 0.001). Similarly, there were significant differences in lesion angle, tortuosity, and calcification between the 2 groups.

10.1371/journal.pone.0237362.t001

###### Comparison of patient's characteristics between the conventional fluoroscopy-time group and the long fluoroscopy-time group.
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                                                       Conventional fluoroscopy-time group, n = 434   Long fluoroscopy-time group, n = 105   p-value
  ---------------------------------------------------- ---------------------------------------------- -------------------------------------- ----------
  Age, years                                           69.2 ± 13.3                                    68.9 ± 13.6                            0.865
  Female, n (%)                                        100 (23.0)                                     21 (20.0)                              0.503
  Physical examination                                                                                                                       
   Height (cm)                                         162.0 ± 9.7 (n = 428)                          163.7 ± 10.4 (n = 104)                 0.141
   Body weight (kg)                                    63.1 ± 13.7 (n = 429)                          64.9 ± 13.7 (n = 103)                  0.234
   Systolic blood pressure at admission (mmHg)         136.8 ± 32.2 (n = 418)                         138.3 ± 38.5 (n = 97)                  0.714
   Diastolic blood pressure at admission (mmHg)        80.6 ± 20.1 (n = 411)                          82.1 ± 21.1 (n = 96)                   0.531
   Heart rate at admission (beat per minute)           79.4 ± 21.6 (n = 424)                          84.6 ± 25.3 (n = 101)                  0.079
   Underlying disease                                                                                                                        
   Hypertension, n (%)                                 327/423 (77.3)                                 81 (77.1)                              0.972
   Diabetes mellitus, n (%)                            164/426 (38.5)                                 54/102(52.9)                           0.008
   Dyslipidemia, n (%)                                 233/416 (56.0)                                 55/103 (53.4)                          0.633
   Hemodialysis, n (%)                                 17 (3.9)                                       10 (9.5)                               0.018
   History of previous PCI, n (%)                      55/433 (12.7)                                  15/104 (14.4)                          0.640
   History of previous CABG, n (%)                     2 (0.5)                                        3 (2.9)                                0.022
   History of previous MI, n (%)                       41/433(9.5)                                    10/104(9.6)                            0.963
  Current smoker, n (%)                                160/422 (37.9)                                 36/103 (35.0)                          0.577
  Medication before admission                                                                                                                
   Aspirin, n (%)                                      72/405 (17.8)                                  19 /96 (19.8)                          0.645
   Thienopyridine, n (%)                               36/404 (8.9)                                   11/96 (11.5)                           0.442
   Beta-blocker, n (%)                                 49/400 (12.3)                                  19/96 (19.8)                           0.054
   ACE-inhibitor, ARB, n (%)                           132/400 (33)                                   42/96 (43.8)                           0.047
   Calcium channel blocker, n (%)                      146/401 (36.4)                                 37/96 (38.5)                           0.697
   Statin, n (%)                                       90/401 (22.4)                                  24/96 (25.0)                           0.593
   Diuretic, n (%)                                     35/402 (8.7)                                   11/96 (11.5)                           0.403
   Hypoglycemic agents, n (%)                          85/402 (21.1)                                  32/96 (33.3)                           0.011
   Insulin, n (%)                                      18/404 (4.5)                                   7/97 (7.2)                             0.262
   Laboratory data at admission                                                                                                              
   Serum creatinine (mg/dl)                            1.1 ± 1.4                                      1.9 ± 2.6                              0.004
   Estimated GFR (ml/min/1.73m^2^)                     67.3 ± 28.3 (n = 433)                          61.7 ± 45.9 (n = 105)                  0.009
   Hemoglobin (g/dl)                                   13.6 ± 2.0                                     13.1 ± 2.1                             0.023
   BNP (pg/ml)                                         281 ± 527 (n = 415)                            457 ± 641 (n = 95)                     0.002
   Onset to hospitalization time, n (%)                                                                                                      
   0--24 hours                                         393 (90.6)                                     85 (81.0)                              0.006
   Longer than 24 hours                                26 (6.0)                                       9 (8.6)                                
   Unknown                                             15 (3.5)                                       11 (10.5)                              
  Killip class                                                                                                                               
   1or2                                                347 (80.0)                                     74 (70.5)                              0.075
   3                                                   32 (7.4)                                       9 (8.6)                                
   4                                                   55 (12.7)                                      22 (21.0)                              
  Cardiac arrest at prehospital or ER, n (%)           25 (5.8)                                       15 (14.3)                              0.003
  Shock vital at prehospital or ER, n (%)              66/427 (15.5)                                  19/105 (18.1)                          0.509
  Culprit lesion                                                                                                                             
   Left main--left anterior descending artery, n (%)   232 (53.5)                                     52 (49.5)                              0.782
   Right coronary artery, n (%)                        159 (36.6)                                     42 (40.0)                              
   Left circumflex, n (%)                              41 (9.4)                                       11 (10.5)                              
   Graft / other, n (%)                                0 (0)                                          0 (0)                                  
   Not determined, n (%)                               2 (0.5)                                        0 (0)                                  
  Number of narrowed coronary arteries                                                                                                       
   1 vessel disease, n (%)                             212 (48.8)                                     40 (38.1)                              \< 0.001
   2 vessel disease, n (%)                             147 (33.9)                                     26 (24.8)                              
   3 vessel disease, n (%)                             75 (17.3)                                      39 (37.1)                              
  Left main trunk lesion, n (%)                        32 (7.4)                                       16 (15.2)                              0.011
  Left main trunk bifurcation lesion, n (%)            17 (3.9)                                       8 (7.6)                                0.106
  Ostia lesion, n (%)                                  21 (4.8)                                       8 (7.6)                                0.257
  Bifurcation lesion, n (%)                            88 (20.3)                                      29 (27.6)                              0.101
  Initial TIMI flow grade of culprit                                                                                                         
   0                                                   243 (56.0)                                     56 (53.3)                              0.823
   1                                                   44 (10.1)                                      13 (12.4)                              
   2                                                   78 (18.0)                                      17 (16.2)                              
   3                                                   69 (15.9)                                      19 (18.1)                              
  Lesion length (mm)                                   15.9 ± 7.2                                     22.5 ± 13.6                            \< 0.001
  Reference diameter (mm)                              2.7 ± 0.7                                      2.6 ± 0.8                              0.194
  Lesion angle                                                                                                                               
   Mild (150°\<)                                       192 (44.2)                                     33 (31.4)                              0.003
   Moderate(120°\<angle≤150°), n (%)                   201 (46.3)                                     51 (48.6)                              
   Severe (≤120°), n (%)                               41 (9.4)                                       21 (20.0)                              
  Tortuosity                                                                                                                                 
   Mild tortuosity, n (%)                              404 (93.1)                                     93 (88.6)                              0.011
   Moderate tortuosity, n (%)                          19 (4.4)                                       3 (2.9)                                
   Excessive tortuosity, n (%)                         11 (2.5)                                       9 (8.6)                                
  Eccentricity                                                                                                                               
   Concentric, n (%)                                   414 (95.4)                                                                            0.386
   Eccentric, n (%)                                    20 (4.6)                                       98 (93.3)                              
  Calcification                                                                                                                              
   None-mild, n (%)                                    352 (81.1)                                     66 (62.9)                              \< 0.001
    Moderate, n (%)                                    54 (12.4)                                      21 (20.0)                              
    Severe, n (%)                                      28 (6.5)                                       18 (17.1)                              
  Occurrence of slow flow in PCI, n (%)                36 (8.3)                                       10 (9.5)                               0.686
  Approach site                                                                                                                              
    Trans-radial coronary intervention, n (%)          273/428 (63.8)                                 56/104 (53.8)                          0.033
    Trans-femoral coronary intervention, n (%)         9/428 (2.1)                                    0/104 (0)                              
    Trans-brachial coronary intervention, n (%)        146/428 (34.1)                                 48/104 (46.2)                          
  Change of approach site, n (%)                       26 (6.0)                                       19 (18.1)                              \< 0.001
  PCI procedure                                                                                                                              
  Plain old balloon angioplasty, n (%)                 19 (4.4)                                       10 (9.5)                               0.136
  Aspiration only, n (%)                               4 (0.9)                                        1 (1.0)                                
  Drug coating balloon angioplasty, n (%)              7 (1.6)                                        1 (1.0)                                
  Bare metal stent, n (%)                              16 (3.7)                                       0                                      
  Drug eluting stent, n (%)                            382 (88.0)                                     93 (88.6)                              
  POBA and aspiration, n (%)                           2 (0.5)                                        0                                      
  Other, n (%)                                         4 (0.9)                                        0                                      
  Size of guiding catheter (Fr)                                                                                                              
   6                                                   320 (73.7)                                     55 (52.4)                              \< 0.001
   7                                                   114 (26.3)                                     48 (45.7)                              
   8                                                   0 (0)                                          2 (1.9)                                
  Number of guiding catheters                                                                                                                
    1                                                  421 (97.0)                                     81 (77.1)                              \< 0.001
    2                                                  13 (3.0)                                       21 (20)                                
    ≥3                                                 0 (0.0)                                        3 (2.9)                                
  Number of guide wires                                                                                                                      
    1                                                  275                                            22                                     \< 0.001
    2                                                  142                                            52                                     
    ≥3                                                 17                                             31                                     
  Number of stents                                                                                                                           
    0                                                  41 (9.4)                                       13 (12.4)                              \< 0.001
    1                                                  371 (85.5)                                     60 (57.1)                              
    2                                                  22 (5.1)                                       31 (29.5)                              
    ≥3                                                 0 (0.0)                                        1 (1.0)                                
  Number of balloons                                                                                                                         
    0                                                  22 (5.1)                                       1 (1.0)                                \< 0.001
    1                                                  227 (52.3)                                     28 (26.7)                              
    2                                                  158 (36.4)                                     46 (43.8)                              
    ≥3                                                 27 (6.2)                                       30 (28.6)                              
  Use of guide-extension-catheter, n(%)                15 (3.5)                                       26 (24.8)                              \< 0.001
  Use of microcatheter, n(%)                           77 (17.7)                                      62 (59.0)                              \< 0.001
  Aspiration, n (%)                                    106 (24.4)                                     32 (30.5)                              0.202
  Rotablator, n (%)                                    0 (0.0)                                        1 (1.0)                                0.042
  IVUS guide, n (%)                                    428 (98.6)                                     105 (100.0)                            0.226
  OCT/OFDI guide, n (%)                                1 (0.2)                                        0 (0.0)                                0.622
  Temporary pacemaker, n (%)                           39 (9.0)                                       12 (11.4)                              0.443
  Intra-aortic balloon pumping support, n (%)          38 (8.8)                                       24 (22.9)                              \< 0.001
  V-A ECMO, n (%)                                      14 (3.2)                                       8 (7.6)                                0.041
  Amount of contrast media (ml)                        120 ± 35                                       171 ± 59                               \< 0.001

Data are expressed as the mean ± SD or number (percentage). A Student's t test was used for normally distributed continuous variables, a Mann-Whitney U test was used for abnormally distributed continuous variables, and a chi-square test was used for categorical variables. There are some missing values for several covariates. In that case, we added sample sizes in the format (N = \*\*\*).

PCI indicates percutaneous coronary intervention; CABG, coronary artery bypass grafting; MI, myocardial infarction; STEMI, ST elevation myocardial infarction; NSTEMI, Non-ST elevation myocardial infarction; ACE, Angiotensin converting enzyme; ARB, Angiotensin II receptor blocker; GFR, glomerular filtration rate; BNP, brain natriuretic peptide; ER, emergency room; TIMI, Thrombolysis in myocardial infarction; IVUS, intravascular ultrasound; OCT/OFDI, optical coherence tomography/optical frequency domain imaging; V-A ECMO, veno-arterial extra-corporeal membranous oxygenation.

The univariate logistic regression models to find the factors associated with the long fluoroscopy-time are shown in [Table 2](#pone.0237362.t002){ref-type="table"}. The prevalence of diabetes mellitus, hemodialysis, and previous CABG was significantly associated with the long fluoroscopy-time. In addition, complex lesion characteristics such as lesion length, lesion angle, tortuosity, and calcification were associated with the long fluoroscopy-time. Furthermore, some procedural characteristics such as size of guiding catheter, use of intra-aortic balloon pumping, and use of veno-arterial extra-corporeal membranous oxygenation were also associated with the long fluoroscopy-time.

10.1371/journal.pone.0237362.t002

###### Univariate logistic regression analysis to find association with the long fluoroscopy time (≥33 minutes).

![](pone.0237362.t002){#pone.0237362.t002g}

  Dependent variable: long fluoroscopy time (≥33 minutes)                             
  ----------------------------------------------------------- ------- --------------- ---------
  ***Patient characteristics***                                                       
  Age                                                         0.998   0.982--1.014    0.835
  Female sex                                                  1.198   0.706--2.030    0.503
  Underlying disease                                                                  
   Height (per 10cm incremental)                              1.156   0.938--1.424    0.174
   Body weight (per 10kg incremental)                         1.112   0.954--1.296    0.173
   Systolic blood pressure (mmHg) (per 10mmHg incremental)    1.015   0.951--1.084    0.650
   Diastolic blood pressure (mmHg) (per 10mmHg incremental)   1.038   0.932--1.157    0.494
   Heart rate (beat per minute) (per 10bpm incremental)       1.103   1.003--1.213    0.043
  Underlying disease                                                                  
   Hypertension                                               0.991   0.595--1.649    0.972
   Diabetes mellitus                                          1.797   1.163--2.777    0.008
   Dyslipidemia                                               0.900   0.584--1.387    0.633
   Hemodialysis                                               2.582   1.146--5.817    0.022
   History of previous MI                                     1.017   0.492--2.104    0.963
   History of previous PCI                                    1.158   0.626--2.144    0.640
   History of previous CABG                                   6.353   1.048--38.516   0.044
  Current smoker                                              0.880   0.561--1.380    0.577
  Medication before admission                                                         
   Aspirin                                                    1.141   0.650--2.004    0.646
   Thienopyridine                                             1.323   0.647--2.705    0.443
   Beta-blocker                                               1.768   0.985--3.171    0.056
   ACE-inhibitor, ARB                                         1.579   1.003--2.486    0.049
   Calcium channel blocker                                    1.095   0.692--1.733    0.697
   Statin                                                     1.152   0.686--1.934    0.593
   Diuretic                                                   1.357   0.662--2.781    0.404
   Hypoglycemic agents                                        1.865   1.146--3.035    0.012
   Insulin                                                    1.668   0.676--4.113    0.267
  Laboratory data at admission                                                        
  Serum creatinine (mg/dl)                                    1.212   1.095--1.342    \<0.001
  Estimated GFR (ml/min/1.73m^2^)                             0.994   0.987--1.001    0.108
  Hemoglobin (g/dl)                                           0.893   0.806--0.989    0.029
  BNP (pg/ml) (per 100pg/ml incremental)                      1.047   1.011--1.083    0.009
  Onset to hospitalization time                                                       
  Longer than 24hours vs. 0--24 hours                         0.625   0.283--1.381    0.245
  Killip class                                                                        
  3--4 vs. 1--2                                               1.827   1.055--3.161    0.031
  Cardiac arrest at prehospital or ER                         2.727   1.382--5.380    0.004
  Shock vital at prehospital or ER                            1.208   0.689--2.120    0.509
  ***Lesion characteristics***                                                        
  Culprit lesion                                                                      
   Left main---left anterior descending artery vs. Others     0.854   0.558--1.309    0.469
  Number of narrowed coronary arteries                                                
   3 vessel disease vs. 1 or 2 vessel disease                 2.828   1.772--4.515    \<0.001
  Left main trunk lesion                                      2.258   1.188--4.294    0.013
  Left main trunk bifurcation lesion                          2.023   0.849--4.823    0.112
  Ostia lesion                                                1.622   0.698--3.771    0.261
  Bifurcation lesion                                          1.500   0.921--2.443    0.103
  Initial TIMI flow grade of culprit                                                  
  3 vs. 0--2                                                  1.169   0.668--2.045    0.585
  Lesion length (mm) (per 10mm incremental)                   1.791   1.448--2.216    \<0.001
  Reference diameter (mm)                                     0.813   0.595--1.112    0.195
  Lesion angle                                                                        
  Severe (≤120°) vs. Mild-moderate(120°\<)                    2.396   1.347--4.264    0.003
  Tortuosity                                                                          
  Moderate-excessive tortuosity vs. Mild tortuosity           3.605   1.454--8.942    0.006
  Eccentricity                                                                        
  Eccentric vs. Concentric                                    1.479   0.608--3.595    0.388
  Calcification                                                                       
  Moderate-severe vs. None-mild                               2.537   1.596--4.031    \<0.001
  Occurrence of slow flow in PCI                              1.164   0.558--2.428    0.686
  ***Procedural characteristics***                                                    
  Approach site                                                                       
  Trans radial coronary intervention vs. TFI or TBI           0.662   0.430--1.021    0.062
  Change of approach site                                     3.467   1.836--6.546    \<0.001
  PCI procedure                                                                       
  Drug eluting stent vs. Others                               1.055   0.541--2.056    0.875
  Size of guiding catheter                                                            
  ≥7 vs. 6Fr                                                  2.552   1.646--3.957    \<0.001
  Number of guiding catheter                                                          
  ≥2 vs. 1                                                    9.595   4.691--19.627   \<0.001
  Number of wire                                                                      
  ≥2 vs. 1                                                    6.525   3.922--10.855   \<0.001
  Number of stent                                                                     
  ≥2 vs. 0--1                                                 8.209   4.513--14.916   \<0.001
  Number of balloon                                                                   
  ≥3 vs. 0--2                                                 6.030   3.392--10.719   \<0.001
  Use of extension guide catheter                             9.193   4.660--18.136   \<0.001
  Use of micro catheter                                       6.685   4.219--10.593   \<0.001
  Use of aspiration catheter                                  1.356   0.848--2.170    0.203
  Temporary pacemaker                                         1.307   0.659--2.593    0.444
  Intra-aortic balloon pumping support                        3.088   1.756--5.428    \<0.001
  V-A ECMO                                                    2.474   1.010--6.063    0.048

The multivariate stepwise logistic regression analysis to find the factors associated with the long fluoroscopy-time is shown in [Table 3](#pone.0237362.t003){ref-type="table"}. The stepwise model included the following variables: previous CABG, serum creatinine levels, hemoglobin levels, Killip class, cardiac arrest at prehospital or emergency room, number of narrowed coronary arteries, left main trunk lesion, lesion length, lesion angle, tortuosity, calcification, and size of guiding catheters. Serum creatinine(OR 1.139, 95% CI 1.016--1.277, P = 0.026), cardiac arrest at prehospital or ER(OR 2.594, 95% CI 1.205--5.584, P = 0.015), triple vessels disease (vs. 1 or 2 vessel diseases: OR 1.772, 95% CI 1.052--2.983, P = 0.031), lesion length (per 10 mm incremental: OR 1.751, 95% CI 1.397--2.195, P \< 0.001), moderate-excessive tortuosity (vs. mild tortuosity: OR 4.006, 95% CI 1.498--10.715, P = 0.006), moderate to severe calcification (vs. none-mild calcification: OR 1.865, 95%CI 1.107--3.140, P = 0.019), and size of guiding catheter ≥7 Fr (vs. 6 Fr: OR 1.751, 95% CI 1.064--2.883, P = 0.028) were significantly associated with the long fluoroscopy-time in this final model.

10.1371/journal.pone.0237362.t003

###### Multivariate logistic regression analysis model to find association with the long fluoroscopy time (≥33 minutes).
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  Dependent variable: long fluoroscopy time (≥33 minutes)                           
  --------------------------------------------------------- ------- --------------- ---------
   Serum creatinine (mg/dl)                                 1.139   1.016--1.277    0.026
   Cardiac arrest at prehospital or ER                      2.594   1.205--5.584    0.015
   Triple vessels disease (vs. 1 or 2 vessel diseases)      1.772   1.052--2.983    0.031
   Lesion length (mm) (per 10mm incremental)                1.751   1.397--2.195    \<0.001
  Moderate-excessive tortuosity (vs. mild tortuosity)       4.006   1.498--10.715   0.006
   Moderate-severe calcification (vs. none-mild)            1.865   1.107--3.140    0.019
  Size of guiding catheter ≥7 Fr (vs. 6 Fr)                 1.751   1.064--2.883    0.028

The stepwise model includes the following variables: History of previous CABG, Serum creatinine (mg/dl), Hemoglobin (g/dl), Killip class, Cardiac arrest at prehospital or ER, Number of narrowed coronary arteries, Left main trunk lesion, Lesion length (mm) (per 10mm incremental), Lesion angle, Tortuosity, Calcification, Size of guiding catheter.

Discussion {#sec013}
==========

The present study included 539 patients who underwent primary PCI for STEMI, which were divided into the conventional fluoroscopy-time group (n = 434) and the long fluoroscopy-time group (n = 105). In the multivariate stepwise logistic regression analysis, serum creatinine, cardiac arrest at prehospital or ER, three vessel disease, diffuse long lesion, moderate to excessive tortuosity, moderate to severe calcification, and big size of guiding catheter were associated with the long fluoroscopy-time, suggesting that complex lesion characteristics required longer fluoroscopy-time in primary PCI.

Although there were several studies to find determinants of the long fluoroscopy time in PCI \[[@pone.0237362.ref014], [@pone.0237362.ref015]\], there were few studies to find that in primary PCI for STEMI. In the present study, lesion length was significantly associated with the long fluoroscopy time. Since the very beginning of PCI, lesion length has been considered to be an important feature reflecting the difficulty of PCI \[[@pone.0237362.ref012], [@pone.0237362.ref016]\]. We previously reported that total fluoroscopy time was clearly stratified according to the ACC/AHA type classification of coronary lesions such as type A, type B, and type C \[[@pone.0237362.ref017]\], and lesion length has been a main component of the ACC/AHA type classification system. Even in the current PCI, strong back-up support should be necessary to deliver devices to the diffuse long lesion, which sometimes requires guide-extension-catheters, buddy wire technique, and anchoring technique \[[@pone.0237362.ref018]\]. Furthermore, diffuse long lesion may require an additional stent to cover the whole lesion. Therefore, diffuse long lesion would require longer fluoroscopy time.

In the present study, moderate-excessive tortuosity was also associated with the long fluoroscopy time. Severe vessel tortuosity has been identified as a predictor of unsuccessful PCI \[[@pone.0237362.ref019]\]. Nikolsky et al. analyzed the reasons of stent deployment failure using 151 cases, and reported that the dominant reason (92%) of stent deployment failure was unsuccessful to deliver the stent to the lesion site, because of severe tortuosity and/or calcification \[[@pone.0237362.ref020]\]. Ho, et al. reported that the current thin-strut stent had better deliverability to coronary lesions, but required "five-in-six" system to facilitate stent delivery for severely tortuous lesions \[[@pone.0237362.ref021]\]. Thus, stent delivery to excessive tortuous lesions still requires additional efforts and the additional fluoroscopy time. Our results suggest that excessive tortuosity can be a problem even in contemporary primary PCI.

Similarly, calcification was significantly associated with the long fluoroscopy time in the present study. Since severe calcification was closely associated with difficulty of device delivery \[[@pone.0237362.ref018], [@pone.0237362.ref021]\], it was expected that longer fluoroscopy time was required in severely calcified lesions. Furthermore, severe calcification can be a cause of balloon underexpansion or balloon rupture \[[@pone.0237362.ref022], [@pone.0237362.ref023]\], which may require additional non-compliant balloons, scoring balloons, or debulking devices \[[@pone.0237362.ref024]\]. Such additional procedures should require longer fluoroscopy time. Since only 1 case (0.2%) required rotablator in our study population, even calcification that did not need rotablator could be a cause of difficulty in primary PCI.

Serum creatinine was associated with the long fluoroscopy-time. Increased serum levels is known to be associated with advanced atherosclerosis \[[@pone.0237362.ref025], [@pone.0237362.ref026]\]. Advance atherosclerosis could be a cause of complex coronary lesions, which might require additional fluoroscopy time. Cardiac arrest at prehospital or ER was also significantly associated with the long fluoroscopy-time. If vital signs were unstable in catheter laboratories, it should be necessary to stabilize severe conditions using vasopressor agents, IABP, or V-A ECMO, which also require some fluoroscopy time. Gupta N et al. showed that patients with cardiac arrest had more complex coronary lesions \[[@pone.0237362.ref027]\]. Similarly, triple vessel disease was associated with the long fluoroscopy-time. Triple vessel disease indicates the progression of coronary atherosclerosis. Sorajja P et al. reported that extensive disease in vessels remote from the infarct-related artery was associated with unsuccessful reperfusion in primary PCI \[[@pone.0237362.ref028]\], which would require longer fluoroscopy time. Lastly, larger size of guiding catheter was significantly associated with the long fluoroscopy-time. However, interpretation of this result should be careful. Since larger guiding catheter size has strong back-up force, we selected larger guiding catheter for lesions with more complex disease. Therefore, larger size of guiding catheter would probably be an effect rather than a cause of longer fluoroscopy-time.

Clinical implications of the present study should be noted. Since primary PCI is performed irrespective of on/off-hours \[[@pone.0237362.ref029]\], junior operators often perform primary PCI with or without senior operators. Although most lesions may be managed by junior operators, some lesions would require experienced senior operators. In fact, Chen, et al. reported that the significant reduction of in-hospital death was observed when primary PCI was performed by trained operators as compared to untrained operators \[[@pone.0237362.ref030]\]. However, it may be difficult for junior operators to differentiate which lesions are really difficult. The present study may provide practical information which lesions are really difficult for junior operators in primary PCI. If the lesion are diffuse long, severely tortuous, or severely calcified in coronary angiography, junior operators should ask senior operators of backup support, if possible. Otherwise, junior operators should discuss the strategy to such tough lesions in primary PCI with senior operators beforehand.

Study limitations {#sec014}
-----------------

First, because this study was a single-center retrospective observational study, there is a risk of patient selection bias. Second, we arbitrary defined the long fluoroscopy-time as the longest quintile of the fluoroscopy time, because there were no established cut-off points for the long fluoroscopy time, which were also used in early literatures \[[@pone.0237362.ref031]--[@pone.0237362.ref033]\]. Moreover, if we defined the long fluoroscopy-time as the longest quartile or the longest sextile, the main parameters such as lesion length, tortuosity, and calcification remained significant determinants of the long fluoroscopy time (data was only shown in the peer review process). Third, since total occlusion was frequently observed in the culprit lesion of STEMI, QCA parameters were measured after the acquisition of reperfusion (after ballooning or thrombectomy). Therefore, these QCA parameters might not reflect the original occlusion length or reference diameter.

Conclusions {#sec015}
===========

In primary PCI for STEMI, serum creatinine, cardiac arrest at prehospital or ER, three vessel disease, diffuse long lesion, moderate-excessive tortuosity, severe calcification were associated with the long fluoroscopy-time. These complex features require special attention to reduce reperfusion time in primary PCI.
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